HIV-1 Tat transcriptional activity is regulated by acetylation

EMBO Journal

Volumn 18, Issue 21, 1999, Pages 6106-6118

  Kiernan, Rosemary E ^a   Vanhulle, Caroline ^b   Schiltz, Lou ^c   Adam, Emmanuelle ^b   Xiao, Hua ^d   Maudoux, Frédéric ^b   Calomme, Claire ^b   Burny, Arsène ^b   Nakatani, Yoshihiro ^c   Jeang, Kuan Teh ^d   Benkirane, Monsef ^a   Van Lint, Carine ^b  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Acetylation; HIV 1 Tat; p300; PCAF; Transcriptional activity

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; PROTEIN KINASE; TRANSACTIVATOR PROTEIN; TRICHOSTATIN A; VIRUS RNA;

ACETYLATION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN RNA BINDING; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

3T3 CELLS; ACETYLATION; ACETYLTRANSFERASES; ANIMALS; CELL CYCLE PROTEINS; CYCLINS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HISTONE ACETYLTRANSFERASES; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MICE; MUTATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RNA, VIRAL; RNA-BINDING PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033230613     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.21.6106     Document Type: Article

References (67)

1. Adams, M., Sharmeen, L., Kimpton, J., Romeo, J.M., Garcia, J.V., Peterlin, B.M., Groudine, M. and Emerman, M. (1994) Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl Acad. Sci. USA, 91, 3862-3866.
2. Ait-Si-Ali, S. et al. (1998) Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature, 396, 184-186.
3. Bannister, A.J. and Kouzarides, T. (1996) The CBP co-activator is a histone acetyltransferase. Nature, 384, 641-643.
4. Benkirane, M., Chun, R.F., Xiao, H., Ogryzko, V.V., Howard, B., Nakatani, Y. and Jeang, K.T. (1998) Activation of integrated provirus requires histone acetyltransferase: p300 and PCAF are coactivators for HIV-1 Tat. J. Biol. Chem., 273, 24898-24905.
5. Berkhout, B., Silverman, R. and Jeang, K.T. (1989) Tat transactivates the human immunodeficiency virus through a nascent RNA target. Cell, 59, 273-282.
6. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P. and Cullen, B.R. (1998) Recruitment of a protein complex containing tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J., 17, 7056-7065.
7. Bohjanen, P.R., Liu, Y. and Garcia-Blanco, M.A. (1997) TAR RNA decoys inhibit tat-activated HIV-1 transcription after preinitiation complex formation. Nucleic Acids Res., 25, 4481-4486.
8. Boyes, J., Byfield, P., Nakatani, Y. and Ogryzko, V. (1998) Regulation of activity of the transcription factor GATA-1 by acetylation. Nature, 396, 594-598.
9. Brand, S.R., Kobayashi, R. and Matthews, M.B. (1997) The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem., 272, 8388-8395.
10. Cannon, P., Kim, S.H., Ulich, C. and Kim, S. (1994) Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J. Virol., 68, 1993-1997.
11. Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y. and Evans, R.M. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell, 90, 569-580.
12. Chun, R.F. and Jeang, K.T. (1996) Requirements for RNA polymerase II carboxy-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-I. J. Biol. Chem., 271, 27888-27894.
13. Chun, R.F., Semmes, O.J., Neuveut, C. and Jeang, K.T. (1998) Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol., 72, 2615-2629.
14. Corbeau, P. and Wong-Staal, F. (1998) Anti-HIV effects of HIV vectors. Virology, 243, 268-274.
15. Cujec, T.P., Cho, H., Maldonado, E., Meyer, J., Reinberg, D. and Peterlin, B.M. (1997a). The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol., 17, 1817-1823.
16. Cujec, T.P., Okamoto, H., Fujinaga, K., Meyer, J., Chamberlin, H., Morgan, D.O. and Peterlin, B.M. (1997b) The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev., 11, 2645-2657.
17. Dingwall, C. et al. (1989) Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl Acad. Sci. USA, 86, 6925-6929.
18. Garber, M.E., Wei, P., KewalRamani, V.N., Mayall, T.P., Herrmann, C.H., Rice, A.P., Littman, D.R. and Jones, K.A. (1998) The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev., 12, 3512-3527.
19. Garcia-Martinez, L.F., Ivanov, D. and Gaynor, R.B. (1997a) Association of Tat with purified HIV-1 and HIV-2 transcription preinitiation complexes. J. Biol. Chem., 272, 6951-6958.
20. Garcia-Martinez, L.F., Mavankal, G., Neveu, J.M., Lane, W.S., Ivanov, D. and Gaynor, R.B. (1997b) Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J., 16, 2836-2850.
21. Grunstein, M. (1997) Histone acetylation in chromatin structure and transcription. Nature, 389, 349-352.
22. Gu, W. and Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
23. Herrmann, C.H. and Rice, A.P. (1993) Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology, 197, 601-608.
24. Herrmann, C.H. and Rice, A.P. (1995) Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxy-terminal domain of the large subunit of RNA polymerase II: candidate for a Tat cofactor. J. Virol., 69, 1612-1620.
25. Herschlag, D. and Johnson, F.B. (1993) Synergism in transcriptional activation: a kinetic view. Genes Dev., 7, 173-179.
26. Hottiger, M.O. and Nabel, G.J. (1998) Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol., 72, 8252-8256.
27. Imhof, A., Yang, X.J., Ogryzko, V.V., Nakatani, Y., Wolffe, A.P. and Ge, H. (1997) Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol., 7, 689-692.
28. Jeang, K.T. (1996) In Myers, G., Korber, B., Foley, B., Jeang, K.T., Mellors, J. and Wain-Hobson, S., (eds), HIV-1 Tat: Structure and Function. Part III, 3-18, Los Alamos National Laboratory, Los Alamos, NM.
29. Jeang, K.T. and Berkhout, B. (1992) Kinetics of HIV-1 long terminal repeat trans-activation. Use of intragenic ribozyme to assess rate-limiting steps. J. Biol. Chem., 267, 17891-17899.
30. Jeang, K.T. and Gatignol, A. (1994) Comparison of regulatory features among primate lentiviruses. Curr. Top. Microbiol. Immunol., 188, 123-144.
31. Jeang, K.T., Chun, R., Lin, N.H., Gatignol, A., Glabe, C.G. and Fan, H. (1993) In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp 1 transcription factor. J. Virol., 67, 6224-6233.
32. Jones, K.A. (1997) Taking a new TAK on tat transactivation. Genes Dev., 11, 2593-2599.
33. Jones, K.A. and Peterlin, B.M. (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem., 63, 717-743.
34. Keen, N.J., Gait, M.J. and Karn, J. (1996) Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc. Natl Acad. Sci. USA, 93, 2505-2510.
35. Keen, N.J., Churcher, M.J. and Karn, J. (1997) Transfer of Tat and release of TAR RNA during the activation of the human immunodeficiency virus type-1 transcription elongation complex. EMBO J., 16, 5260-5272.
36. Li, Q., Herrler, M., Landsberger, N., Kaludov, N., Ogryzko, V.V., Nakatani, Y. and Wolffe, A.P. (1998) Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo. EMBO J., 17, 6300-6315.
37. Lisziewicz, J. et al. (1993) Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc. Natl Acad. Sci. USA, 90, 8000-8004.
38. Mancebo, H.S. et al. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev., 11, 2633-2644.
39. Marzio, G., Tyagi, M., Gutierrez, M.I. and Giacca, M. (1998) HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl Acad. Sci. USA, 95, 13519-13524.
40. McMillan, N.A. et al. (1995) HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology, 213, 413-424.
41. Mizzen, C.A. and Allis, C.D. (1998) Linking histone acetylation to transcriptional regulation. Cell. Mol. Life Sci., 54, 6-20.
42. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G. and Thanos, D. (1998) Acetylation of HMG I (Y) by CBP turns off IFNβ expression by disrupting the enhanceosome. Mol. Cell, 2, 457-467.
43. Myers, G., Hahn, B.H., Mellors, J.W., Henderson, L.E., Korber, B., Jeang, K.T., McCutchan, F.E. and Pavlakis, G.N. (1995) Human Retroviruses and AIDS. Compilation and analysis of nucleic acid and amino acid sequences. Los Alamos National Laboratory, Los Alamos, NM
44. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
45. Okamoto, H., Sheline, C.T., Corden, J.L., Jones, K.A. and Peterlin, B.M. (1996) Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl Acad. Sci. USA, 93, 11575-11579.
46. Ott, M., Emiliani, S., Van Lint, C., Herbein, G., Lovett, J., Chirmule, N., McCloskey, T., Pahwa, S. and Verdin, E. (1997) Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway. Science, 275, 1481-1485.
47. Parada, C.A. and Roeder, R.G. (1996) Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature, 384, 375-378.
48. Pazin, M.J. and Kadonaga, J.T. (1997) What's up and down with histone deacetylation and transcription? Cell, 89, 325-328.
49. Peng, H., Reinhart, T.A., Retzel, E.F., Staskus, K.A., Zupancic, M. and Haase, A.T. (1995) Single cell transcript analysis of human immunodeficiency virus gene expression in the transition from latent to productive infection. Virology, 206, 16-27.
50. Peng, J., Zhu, Y., Milton, J. and Price, D.H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes Dev., 12, 755-762.
51. Sakaguchi, K., Herrera, J.E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C.W. and Appella, E. (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev., 12, 2831-2841.
52. Sheridan, P.L., Mayall, T.P., Verdin, E. and Jones, K.A. (1997) Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev., 11, 3327-3340.
53. Spencer, T.E. et al. (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature, 389, 194-198.
54. Steger, D.J., Eberharter, A., John, S., Grant, P.A. and Workman, J.L. (1998) Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc Natl Acad. Sci USA, 95, 12924-12929.
55. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev., 12, 599-606.
56. Torchia, J., Rose, D.W., Inostroza, J., Kamei, Y., Westin, S., Glass, C.K. and Rosenfeld, M.G. (1997) The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature, 387, 677-684.
57. Van Lint, C., Ghysdael, J., Paras, P., Jr, Burny, A. and Verdin, E. (1994) A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J. Virol., 68, 2632-2648.
58. Van Lint, C., Emiliani, S., Ott, M. and Verdin, E. (1996a) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J., 15, 1112-1120.
59. Van Lint, C., Emiliani, S. and Verdin, E. (1996b) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr., 5, 245-253.
60. Waltzer, L. and Bienz, M. (1998) Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling. Nature, 395, 521-525.
61. Wang, S., Huber, P.W., Cui, M., Czarnik, A.W. and Mei, H.Y. (1998) Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism. Biochemistry, 37, 5549-5557.
62. Wei, P., Garber, M.E., Fang, S.M., Fischer, W.H. and Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92, 451-462.
63. Yang, X., Herrmann, C.H. and Rice, A.P. (1996) The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxy-terminal domain of RNA polymerase II for function. J. Virol., 70, 4576-4584.
64. Yang, X., Gold, M.O., Tang, D.N., Lewis, D.E., Aguilar-Cordova, E., Rice, A.P. and Herrmann, C.H. (1997) TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl Acad. Sci. USA, 94, 12331-12336.
65. Yoshida, M., Kijima, M., Akita, M. and Beppu, T. (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem., 265, 17174-17179.
66. Zhang, W. and Bieker, J.J. (1998) Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases. Proc. Natl Acad. Sci. USA, 95, 9855-9860.
67. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B. and Price, D.H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev., 11, 2622-2632.